Chronic lymphocytic leukaemia+1
RecruitingA Study Comparing DZD8586 to Other Treatments for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded
A Study Comparing DZD8586 to Other Treatments for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Has Returned or Not Responded
- Disease:Chronic lymphocytic leukaemiaB-cell small lymphocytic lymphoma
- Substances:IdelalisibRituximab+2
Italy- Participants:18–64 years · 65+ years
- Substances:Idelalisib








